人神经母细胞瘤细胞SH-SY5YFH0156
价格：￥1500
品牌名称：富衡型号：FH0156 原产地：中国大陆 更新时间：2026/10/21 7:56:21
产品摘要：SH - SY5Y 细胞在神经科学研究领域应用广泛，常被用于神经退行性疾病、神经发育以及药物研发等方面的研究，有助于深入了解神经母细胞瘤的发病机制和探索相关治疗策略。
支付方式：
- 支付宝 微信 银行转账
产品完善度： 访问次数：591
企业档案
会员类型：旗舰版
已获得阿仪网信誉 等级评定
61成长值
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
阿仪网旗舰版会员：3年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
参观次数：630501
详细内容
| 产品名称 | 人神经母细胞瘤细胞；SH-SY5Y (STR) |
|---|---|
| 品牌 | FuHeng |
| 英文名 | SH-SY5Y (STR) |
| 货号 | FH0156 |
| 规格 | 1×10⁶cells/T25培养瓶 |
| 价格 | 1500.0 |
| 培养 | DMEM+10%FBS |
| 别称 | SH-Sy5y; SHSY5Y; SHSY-5Y; SK-SH-SY5Y; SY5Y; SH-SY5Y Parental |
| 形态特征 | 上皮样 |
| 生长特性 | 贴壁生长 |
| 培养条件 | 气相：空气，95%；CO2,5%温度：37℃ |
| 传代方法 | 1：2传代 |
| 组织来源 | 骨髓 |
| 细胞简介 | SH - SY5Y 细胞在神经科学研究领域应用广泛，常被用于神经退行性疾病、神经发育以及药物研发等方面的研究，有助于深入了解神经母细胞瘤的发病机制和探索相关治疗策略。 |
| 特征特性 | 据报道，该细胞的密度可高达1×106cells/cm2，具有中等水平的多巴胺β羟化酶的活性。 |
| 培养基 | SH-SY5Y完全培养基 |
富衡相关文献
| 论文标题 | DOI | 发表时间 | 期刊 | 影响因子 | 作者列表 |
| Identification of the disulfidptosis-related gene IQGAP1 as a potential diagnostic biomarker in Parkinson’s disease | 10.1016/j.brainres.2026.150153 | 2026-01-06 | BRAIN RESEARCH | 2.6 | Jianlin Li, Jianhang You, Zaipu Li, Jing Zang, Lin Wu, Tao Zhao |
| Hypoxia-induced LONP1 overexpression and mtDNA damage may serve as biomarkers for death from mechanical asphyxia | 10.1016/j.legalmed.2025.102769 | 2025-12-24 | Legal Medicine | 1.4 | Tianpu Wu, Heng Zhang, Dongchuan Zhang, Yikai Hu, Lu Tian, Wencan Li, Fu Zhang, Bi Xiao, Jianlong Ma, Yi Shi, Yue Chen, Hanfeng Jiang, Xinbiao Liao, Kaijun Ma, Long Chen |
| SIRT2-mediated autophagy as a target of Butylphthalide in the treatment of ischemic stroke | 10.1016/j.bbrc.2025.152588 | 2025-09-03 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 2.2 | Hai-Qian Zhou, Hai-Tao Gao, Wen-Mei Lu, Wen-Liang Jiang, Dan-Hong Wu |
| Atractylenolide III Mitigates Alzheimer's Disease by Enhancing Autophagy via the YY1-TFEB Pathway | 10.1002/ptr.70069 | 2025-08-20 | PHYTOTHERAPY RESEARCH | 6.3 | Xiaowei Zhang, Shuang Chu, Yanli Huang, Zhonghua Li, Junying Song, Pan Wang, Yunfang Su, Zhenqiang Zhang, Zhishen Xie |
| Blue Honeysuckle (Lonicera caerulea L.)-anthocyanins and Cyanidin-3-O-glucoside Protect Dopaminergic Neurons Against Ferroptosis by Activating the Nrf2-GPX7 Axis | 10.1016/j.freeradbiomed.2025.07.038 | 2025-07-28 | FREE RADICAL BIOLOGY AND MEDICINE | 8.2 | Xiao-Na Li, Li-Li Fan, Qian Zhu, Jia-Hui Liu, Zhen-Yan Xie, Jia-Lin Cao, Jun-Yu Tan, Li Lin, Xue-Song Li, Xin-Hua Wei |
| P2X7R activation promotes ferroptosis in dopaminergic neurons via NF-κB signaling pathway in vitro and in vivo models of MPP+/MPTP-induced Parkinson’s disease | 10.1016/j.brainres.2025.149824 | 2025-07-08 | BRAIN RESEARCH | 2.6 | Yao Si, Shi Yan, Xueying Li, Wencai Ding, Xinyu Zhang, Kejuan Jia, Lifen Yao, Fan Yang, Wanying Shi |
| Endoplasmic Reticulum Stress Inhibition Promotes Mitophagy via Miro1 Reduction to Rescue Mitochondrial Dysfunction and Protect Dopamine Neurons in Parkinson’s Disease | 10.1007/s10571-025-01575-9 | 2025-05-29 | CELLULAR AND MOLECULAR NEUROBIOLOGY | 4.8 | Wen Yuqi, Han Zheng, Wang Bao, Feng Chenxi, Ding Xvshen, Li Yangni, Lv Yan, Wang Xuelian, Gao Li |
| Ultrasmall Nanoparticles Mitigate Tau Hyperphosphorylation to Restore Synaptic Integrity and Boost Cognitive Function in Alzheimer's Disease | 10.1002/adhm.202500941 | 2025-05-16 | Advanced Healthcare Materials | 9.6 | Hanbing Xu, Gang Wang, Zhilin Jiang, Yaobao Han, Weiming Zhao, Hao Zhang, Hong Liu, Huayue Liu, Zhen Li, Fuhai Ji |
| Minocycline nanoplatｆorm penetrates the BBB and enables the targeted treatment of Parkinson's disease with cognitive impairment | 10.1016/j.jconrel.2024.11.066 | 2024-11-29 | JOURNAL OF CONTROLLED RELEASE | 10.5 | Guowang Cheng, Zhiwen Liu, Zhao Yan, Jiaxin Wu, Zilin Li, Sijia Gao, Chunye Zheng, Shuanshuan Guo, Yue Pan, Xiaojia Chen, Guanghui Lin, Jianhua Zhou, Tongkai Chen |
| Identification of copper ｍmbedbolism-related markers in Parkinson’s disease | 10.1080/07853890.2024.2425064 | 2024-11-18 | ANNALS OF MEDICINE | 4.9 | Jie Lin, Guifeng Zhang, Bo Lou, Yi Sun, Xiaodong Jia, Meidan Wang, Jing Zhou, Zhangyong Xia |
| UCH-L1 Inhibitor Alleviates Nerve Damage Caused by Moyamoya Disease | 10.1155/2024/2550642 | 2024-07-25 | Applied Bionics and Biomechanics | 1.8 | Minghua Xu, Xiaomin Zhao, Jiang Zhao, Zhisheng Tan, Chengshi Zhang, Yun Huang, Huiping Zhong, Meifeng Guo, Chen Zhang, Ping Ye, Wentao Zheng |
| Sensitizing TRAIL response via differential modulation of anti- and pro-apoptotic factors by AZD5582 combined with ER nanosomal TRAIL in neuroblastoma | 10.1016/j.acthis.2022.151856 | 2022-01-22 | ACTA HISTOCHEMICA | 2.147 | Chaohong Huang, Yujie He, Jianwu Sun, Qian Yuan, Shuyi Li, Huan Hou, Kui Su, Changhong Ke, Zhiyun Du, Zhengqiang Yuan |
| Extracellular Vesicle Delivery of TRAIL Eradicates Resistant Tumor Growth in Combination with CDK Inhibition by Dinaciclib | 10.3390/cancers12051157 | 2020-05-04 | Cancers | 6.126 | Changhong Ke, Huan Hou, Jiayu Li, Kui Su, Chaohong Huang, Yue Lin, Zhiqiang Lu, Zhiyun Du, Wen Tan, Zhengqiang Yuan |
上海衡生物科技有限公司
上海富衡生物科技有限公司（以下简称“富衡”）是主要从事生物科技，医药科技领域内的技术开发，技术咨询，技术服务的高新技术企业。是一家专注于细胞相关技术，服务及产品的高科技生命科学和生物技术领域企业。
富衡提供专业的细胞鉴定服务（采用ATCC细胞鉴定准－－STR基因分型技术），并建立完善鉴定，种类齐全的细胞资源库，能为广大科研工作者在发表高质量文章时提供可靠的“细胞鉴定依据”。公司拥有一个蓬勃朝气的年轻团队，不断进取，我们密切注视细胞技术领域的发展，并且于员工的技术和素质培训。团队中博士硕士以上学历人士达80％，有很强的技术支持及研发能力。
专注于细胞培养 PARTNERS 合作伙伴
热门标签：人神经母细胞瘤细胞SH-SY5Y,SH-SY5Y,SH-SY5Y细胞
